Skip to main content
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.75
-2.96 (-30.48%)
At close: Feb 27, 2026, 4:00 PM EST
6.68
-0.07 (-1.04%)
After-hours: Feb 27, 2026, 7:57 PM EST

Ginkgo Bioworks Holdings Revenue

In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. Ginkgo Bioworks Holdings had revenue of $33.40M in the quarter ending December 31, 2025, a decrease of -23.84%.

Revenue (ttm)
$170.16M
Revenue Growth
-25.06%
P/S Ratio
2.25
Revenue / Employee
$204,023
Employees
834
Market Cap
383.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
CorMedix 214.30M
Zevra Therapeutics 84.39M
Fulcrum Therapeutics 80.00M
ADC Therapeutics 75.21M
Altimmune 20.00K
Revenue Rankings

DNA News

More News